Igor Gorbatchevsky, MD
About Igor Gorbatchevsky, MD
Igor Gorbatchevsky, MD, is a seasoned oncology drug development expert with over 20 years of experience, currently serving as the Chief Medical Officer.
Igor Gorbatchevsky, MD - Chief Medical Officer
Dr. Igor Gorbatchevsky currently serves as the Chief Medical Officer. With significant responsibilities, he oversees the medical aspects of the organization's operations, ensuring the development and implementation of clinical strategies. His extensive experience in the oncology drug development field reinforces his leadership capabilities in this pivotal role.
Igor Gorbatchevsky's Background in Oncology Drug Development
Dr. Igor Gorbatchevsky has over two decades of hands-on experience in oncology drug development. His professional journey spans various esteemed positions, including being the VP of Clinical Development at MEI Pharma and the VP of Clinical Science at Iovance Biotherapeutics. His specialized knowledge in oncology drug development has cemented his reputation in the medical community.
Igor Gorbatchevsky's Role in ALIQOPA Development at Bayer
During his tenure at Bayer Pharmaceuticals, Dr. Igor Gorbatchevsky led the Global Clinical Development Team for ALIQOPA, a pan-PI3K inhibitor. Under his leadership, ALIQOPA received FDA approval for the treatment of patients with follicular lymphoma. This achievement highlights his expertise in clinical development and regulatory processes.
Medical Positions Held by Dr. Igor Gorbatchevsky
Dr. Igor Gorbatchevsky's career includes several high-profile roles in leading pharmaceutical companies. He served as a Global Clinical Leader at Bayer Pharmaceuticals, Senior Medical Director at Daiichi-Sankyo, and included significant contributions in these capacities. These positions underline his extensive experience and leadership in the field.
Igor Gorbatchevsky's Medical Training and Clinical Expertise
Dr. Igor Gorbatchevsky received his medical training at Omsk State Medical Academy, followed by specialty training in clinical immunology at Chelyabinsk State Medical Academy. As a practicing clinician, he treated a broad range of tumor types in both adults and children, which provides him with a profound understanding of clinical practices and patient care.